ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,044 | -96.7% | 56 | -95.3% | 0.00% | -100.0% |
| Q2 2023 | $31,280 | -6.4% | 1,204 | +3.4% | 0.00% | 0.0% |
| Q1 2023 | $33,431 | -2.0% | 1,164 | +1.0% | 0.00% | -25.0% |
| Q4 2022 | $34,099 | +31.2% | 1,152 | +7.5% | 0.00% | +33.3% |
| Q3 2022 | $26,000 | +2500.0% | 1,072 | +3596.6% | 0.00% | – |
| Q2 2022 | $1,000 | – | 29 | +45.0% | 0.00% | – |
| Q3 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 20 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 20 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 20 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $1,000 | – | 20 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |